Morgan Stanley reiterated coverage on Evelo Biosciences with a new price target

5/3/21 8:04:40 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Morgan Stanley reiterated coverage of Evelo Biosciences with a rating of Equal-Weight and set a new price target of $13.00 from $14.00 previously

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$EVLO

Date	Price Target	Rating	Analyst
11/2/2021	$44.00 → $41.50	Market Outperform	JMP Securities
11/1/2021	$12.00	Neutral → Buy	Chardan Capital Markets
6/23/2021	$36.00 → $38.00	Market Outperform	JMP Securities
6/23/2021	$28.00	Overweight	Cantor Fitzgerald